Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?

Ther Adv Cardiovasc Dis. 2021 Jan-Dec:15:17539447211042714. doi: 10.1177/17539447211042714.
No abstract available

Keywords: Inflammation; atherosclerosis; colchicine.

Publication types

  • Editorial

MeSH terms

  • Atherosclerosis* / drug therapy
  • Atherosclerosis* / prevention & control
  • Colchicine / adverse effects
  • Humans
  • Inflammation / diagnosis
  • Inflammation / drug therapy
  • Plaque, Atherosclerotic* / drug therapy

Substances

  • Colchicine